CRH affects the phenotypic expression of sepsis-associated virulence factors by Streptococcus pneumoniae serotype 1 In vitro

Colette G. Ngo Ndjom, Lindsay V. Kantor, Harlan Jones

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Sepsis is a life-threatening health condition caused by infectious pathogens of the respiratory tract, and accounts for 28–50% of annual deaths in the US alone. Current treatment regimen advocates the use of corticosteroids as adjunct treatment with antibiotics, for their broad inhibitory effect on the activity and production of pro-inflammatory mediators. However, despite their use, corticosteroids have not proven to be able to reverse the death incidence among septic patients. We have previously demonstrated the potential for neuroendocrine factors to directly influence Streptococcus pneumoniae virulence, which may in turn mediate disease outcome leading to sepsis and septic shock. The current study investigated the role of Corticotropin-releasing hormone (CRH) in mediating key markers of pneumococcal virulence as important phenotypic determinants of sepsis and septic shock risks. In vitro cultures of serotype 1 pneumococcal strain with CRH promoted growth rate, increased capsule thickness and penicillin resistance, as well as induced pneumolysin gene expression. These results thus provide significant insights of CRH–pathogen interactions useful in understanding the underlying mechanisms of neuroendocrine factor's role in the onset of community acquired pneumonias (CAP), sepsis and septic shock.

Original languageEnglish
Article number263
JournalFrontiers in Cellular and Infection Microbiology
Volume7
Issue numberJUN
DOIs
StatePublished - 22 Jun 2017

Fingerprint

Corticotropin-Releasing Hormone
Virulence Factors
Streptococcus pneumoniae
Sepsis
Septic Shock
Virulence
Adrenal Cortex Hormones
Penicillin Resistance
Respiratory System
Capsules
Pneumonia
Anti-Bacterial Agents
Gene Expression
Serogroup
In Vitro Techniques
Incidence
Health
Therapeutics
Growth

Keywords

  • Corticotropin releasing hormone
  • Phenotype
  • Sepsis virulence
  • Serotypes
  • Streptococcus pneumoniae

Cite this

@article{585efc99319d463f94e34420d6031e99,
title = "CRH affects the phenotypic expression of sepsis-associated virulence factors by Streptococcus pneumoniae serotype 1 In vitro",
abstract = "Sepsis is a life-threatening health condition caused by infectious pathogens of the respiratory tract, and accounts for 28–50{\%} of annual deaths in the US alone. Current treatment regimen advocates the use of corticosteroids as adjunct treatment with antibiotics, for their broad inhibitory effect on the activity and production of pro-inflammatory mediators. However, despite their use, corticosteroids have not proven to be able to reverse the death incidence among septic patients. We have previously demonstrated the potential for neuroendocrine factors to directly influence Streptococcus pneumoniae virulence, which may in turn mediate disease outcome leading to sepsis and septic shock. The current study investigated the role of Corticotropin-releasing hormone (CRH) in mediating key markers of pneumococcal virulence as important phenotypic determinants of sepsis and septic shock risks. In vitro cultures of serotype 1 pneumococcal strain with CRH promoted growth rate, increased capsule thickness and penicillin resistance, as well as induced pneumolysin gene expression. These results thus provide significant insights of CRH–pathogen interactions useful in understanding the underlying mechanisms of neuroendocrine factor's role in the onset of community acquired pneumonias (CAP), sepsis and septic shock.",
keywords = "Corticotropin releasing hormone, Phenotype, Sepsis virulence, Serotypes, Streptococcus pneumoniae",
author = "{Ngo Ndjom}, {Colette G.} and Kantor, {Lindsay V.} and Harlan Jones",
year = "2017",
month = "6",
day = "22",
doi = "10.3389/fcimb.2017.00263",
language = "English",
volume = "7",
journal = "Frontiers in Cellular and Infection Microbiology",
issn = "2235-2988",
publisher = "Frontiers Media S.A.",
number = "JUN",

}

CRH affects the phenotypic expression of sepsis-associated virulence factors by Streptococcus pneumoniae serotype 1 In vitro. / Ngo Ndjom, Colette G.; Kantor, Lindsay V.; Jones, Harlan.

In: Frontiers in Cellular and Infection Microbiology, Vol. 7, No. JUN, 263, 22.06.2017.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - CRH affects the phenotypic expression of sepsis-associated virulence factors by Streptococcus pneumoniae serotype 1 In vitro

AU - Ngo Ndjom, Colette G.

AU - Kantor, Lindsay V.

AU - Jones, Harlan

PY - 2017/6/22

Y1 - 2017/6/22

N2 - Sepsis is a life-threatening health condition caused by infectious pathogens of the respiratory tract, and accounts for 28–50% of annual deaths in the US alone. Current treatment regimen advocates the use of corticosteroids as adjunct treatment with antibiotics, for their broad inhibitory effect on the activity and production of pro-inflammatory mediators. However, despite their use, corticosteroids have not proven to be able to reverse the death incidence among septic patients. We have previously demonstrated the potential for neuroendocrine factors to directly influence Streptococcus pneumoniae virulence, which may in turn mediate disease outcome leading to sepsis and septic shock. The current study investigated the role of Corticotropin-releasing hormone (CRH) in mediating key markers of pneumococcal virulence as important phenotypic determinants of sepsis and septic shock risks. In vitro cultures of serotype 1 pneumococcal strain with CRH promoted growth rate, increased capsule thickness and penicillin resistance, as well as induced pneumolysin gene expression. These results thus provide significant insights of CRH–pathogen interactions useful in understanding the underlying mechanisms of neuroendocrine factor's role in the onset of community acquired pneumonias (CAP), sepsis and septic shock.

AB - Sepsis is a life-threatening health condition caused by infectious pathogens of the respiratory tract, and accounts for 28–50% of annual deaths in the US alone. Current treatment regimen advocates the use of corticosteroids as adjunct treatment with antibiotics, for their broad inhibitory effect on the activity and production of pro-inflammatory mediators. However, despite their use, corticosteroids have not proven to be able to reverse the death incidence among septic patients. We have previously demonstrated the potential for neuroendocrine factors to directly influence Streptococcus pneumoniae virulence, which may in turn mediate disease outcome leading to sepsis and septic shock. The current study investigated the role of Corticotropin-releasing hormone (CRH) in mediating key markers of pneumococcal virulence as important phenotypic determinants of sepsis and septic shock risks. In vitro cultures of serotype 1 pneumococcal strain with CRH promoted growth rate, increased capsule thickness and penicillin resistance, as well as induced pneumolysin gene expression. These results thus provide significant insights of CRH–pathogen interactions useful in understanding the underlying mechanisms of neuroendocrine factor's role in the onset of community acquired pneumonias (CAP), sepsis and septic shock.

KW - Corticotropin releasing hormone

KW - Phenotype

KW - Sepsis virulence

KW - Serotypes

KW - Streptococcus pneumoniae

UR - http://www.scopus.com/inward/record.url?scp=85027504859&partnerID=8YFLogxK

U2 - 10.3389/fcimb.2017.00263

DO - 10.3389/fcimb.2017.00263

M3 - Article

VL - 7

JO - Frontiers in Cellular and Infection Microbiology

JF - Frontiers in Cellular and Infection Microbiology

SN - 2235-2988

IS - JUN

M1 - 263

ER -